Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Morbus Crohn mit Wachstumsstörung

Die Wachstumsstörung im Zusammenhang mit einem Morbus Crohn wird durch somatische Mutationen im IL6 vermittelt.

Gliederung

Veranlagung für entzündliche Darmerkrankungen
Entzündliche Darmerkrankung 25
Entzündliche Darmerkrankung 28
Morbus Crohn mit Wachstumsstörung
IL6
SEL1L
Veranlagung für entzündliche Darmerkrankungen 13

Referenzen:

1.

Kühn R et. al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis.

external link
2.

Farmer MA et. al. (2001) A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice.

external link
3.

Singh UP et. al. (2003) Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice.

external link
4.

Asano K et. al. (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population.

external link
5.

Sawczenko A et. al. (2005) Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children.

external link
6.

Moehle C et. al. (2006) Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

external link
7.

Nenci A et. al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation.

external link
8.

Ricciardelli I et. al. (2008) Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

external link
9.

None (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

external link
10.

Hugot JP et. al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

external link
11.

van Heel DA et. al. (2003) The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants.

external link
12.

Maeda S et. al. (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

external link
13.

van Heel DA et. al. () Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

external link
14.

Rivas MA et. al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

external link
15.

Iliev ID et. al. (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis.

external link
16.

Villani AC et al. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.

external link
17.

Cao Z et. al. (2015) Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.

external link
18.

Lewkonia RM et. al. (1976) Progress report. Familial inflammatory bowel disease--heredity or environment?

external link
19.

Orholm M et. al. (1991) Familial occurrence of inflammatory bowel disease.

external link
20.

Monsén U et. al. (1989) Evidence for a major additive gene in ulcerative colitis.

external link
21.

Küster W et. al. (1989) The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives.

external link
22.

Greenstein AJ et. al. (1988) Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

external link
23.

Sheehan RG et. al. (1967) Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency.

external link
24.

Grönhagen-Riska C et. al. (1983) Familial occurrence of sarcoidosis and Crohn's disease.

external link
25.

Farmer RG et. al. (1980) Studies of family history among patients with inflammatory bowel disease.

external link
26.

Schwartz SE et. al. (1980) Regional enteritis: evidence for genetic transmission by HLA typing.

external link
27.

Targan SR et. al. (1995) Clarifying the causes of Crohn's.

external link
28.

Hermiston ML et. al. (1995) Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin.

external link
29.

Hugot JP et. al. (1994) Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D.

external link
30.

Gilberts EC et. al. (1994) Molecular evidence for two forms of Crohn disease.

external link
31.

Yang H et. al. (1993) Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

external link
32.

None (1996) Complex traits on the map.

external link
33.

Hugot JP et. al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

external link
34.

Satsangi J et. al. (1996) Clinical patterns of familial inflammatory bowel disease.

external link
35.

Neurath MF et. al. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice.

external link
36.

Mishina D et. al. (1996) On the etiology of Crohn disease.

external link
37.

Satsangi J et al. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12.

external link
38.

Ohmen JD et. al. (1996) Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

external link
39.

Parkes M et. al. (1996) Susceptibility loci in inflammatory bowel disease.

external link
40.

Haapamäki MM et. al. (1997) Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

external link
41.

Cho JH et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

external link
42.

Cavanaugh JA et. al. (1998) Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16.

external link
43.

Hampe J et. al. (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

external link
44.

Pizarro TT et. al. (1999) IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.

external link
45.

Annese V et. al. (1999) Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study.

external link
46.

Cattan D et al. (2000) Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever.

external link
47.

Rioux JD et. al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.

external link
48.

Forabosco P et. al. (2000) Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.

external link
49.

Lawrance IC et. al. (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes.

external link
50.

Mwantembe O et. al. (2001) Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals.

external link
51.

Cavanaugh J et. al. (2001) International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16.

external link
52.

Dechairo B et. al. (2001) Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3).

external link
53.

Ten Hove T et. al. (2001) Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice.

external link
54.

Zouali H et. al. (2001) Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease.

external link
55.

Corbaz A et. al. (2002) IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease.

external link
56.

Miller DH et. al. (2003) A controlled trial of natalizumab for relapsing multiple sclerosis.

external link
57.

Ghosh S et. al. (2003) Natalizumab for active Crohn's disease.

external link
58.

von Andrian UH et. al. (2003) Alpha4 integrins as therapeutic targets in autoimmune disease.

external link
59.

Lovato P et. al. (2003) Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease.

external link
60.

Karban AS et. al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.

external link
61.

Hofseth LJ et. al. (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

external link
62.

van Heel DA et. al. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs.

external link
63.

Fuss IJ et. al. (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

external link
64.

Lo SH et. al. (2004) A demonstration and findings of a statistical approach through reanalysis of inflammatory bowel disease data.

external link
65.

Barnich N et. al. (2005) GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells.

external link
66.

McGovern DP et. al. (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.

external link
67.

Oliver J et. al. (2005) A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population.

external link
68.

Mirza MM et. al. (2005) No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort.

external link
69.

Borm ME et. al. (2005) A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.

external link
70.

Gonzalez-Rey E et. al. (2006) Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

external link
71.

Gaya DR et. al. (2006) New genes in inflammatory bowel disease: lessons for complex diseases?

external link
72.

Yen D et. al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

external link
73.

Fellermann K et. al. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.

external link
74.

Kullberg MC et. al. (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

external link
75.

Rioux JD et. al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.

external link
76.

Libioulle C et. al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.

external link
77.

Baumgart DC et. al. (2007) Inflammatory bowel disease: cause and immunobiology.

external link
78.

Barnich N et. al. (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

external link
79.

Parkes M et. al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.

external link
80.

Raelson JV et. al. (2007) Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

external link
81.

Cho JH et. al. (2007) The genetics of inflammatory bowel disease.

external link
82.

None (2008) New links to the pathogenesis of Crohn disease provided by genome-wide association scans.

external link
83.

Pang YH et. al. (2007) Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients.

external link
84.

Shugart YY et. al. (2008) An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29.

external link
85.

Franke A et. al. (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

external link
86.

Zhernakova A et. al. (2008) Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.

external link
87.

Barrett JC et. al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

external link
88.

Martínez A et. al. (2008) Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases.

external link
89.

Franke A et. al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

external link
90.

Anderson CA et. al. (2009) Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.

external link
91.

Silverberg MS et. al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study.

external link
92.

Weersma RK et. al. (2009) Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.

external link
93.

Wang K et. al. (2009) Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.

external link
94.

Glas J et. al. (2009) rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.

external link
95.

Abraham C et. al. (2009) Inflammatory bowel disease.

external link
96.

Wang K et. al. (2010) Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.

external link
97.

Franke A et. al. (2010) Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).

external link
98.

McGovern DP et. al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci.

external link
99.

McGovern DP et. al. (2010) Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

external link
100.

Fransen K et. al. (2010) Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease.

external link
101.

Momozawa Y et. al. (2011) Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.

external link
102.

Khor B et. al. (2011) Genetics and pathogenesis of inflammatory bowel disease.

external link
103.

Elding H et. al. (2011) Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease.

external link
104.

Jostins L et. al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

external link
105.

None (1996) Genetics of inflammatory bowel disease.

external link
106.

Yoneno K et. al. (2013) TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease.

external link
107.

Adolph TE et. al. (2013) Paneth cells as a site of origin for intestinal inflammation.

external link
108.

Monteleone G et. al. (2015) Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

external link
109.

Huang H et. al. (2017) Fine-mapping inflammatory bowel disease loci to single-variant resolution.

external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz